Kidney Transplantation clinical trials

Explore recruiting kidney transplantation clinical trials.

Recruiting kidney transplantation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Kidney Transplantation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Randomized controlled trial evaluating the impact of mineralocorticoid receptor blockade by eplerenone on echocardiographic abnormalities among kidney graft recipient under calcineurin inhibitors. KT-CANOPY: Cardiac improvement by eplerenone among patients under cyclosporine or tacrolimus for kidney transplantation.

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

A seamless Phase 2/3 randomized, open-label study to investigate efficacy and safety of frexalimab versus tacrolimus in adult kidney transplant recipients

Germany, Hungary, Italy, Belgium, Czechia, Finland +6 more

Phase II and Phase III (Integrated) EU CTIS Study details

A randomized trial of tacrolimus monotherapy compared to standard triple immune suppressive medication in elderly recipients of a kidney transplant to reduce infection-related mortality and improve quality of life; the TACMONO-XL study.

Netherlands

Therapeutic use (Phase IV) EU CTIS Study details

Prospective, multicenter, randomized, open-label, parallel-group controlled phase 3 study of tacrolimus minimization in kidney transplant recipients selected according to the AGORA algorithm for their low immunological risk and medium-term graft failure

Spain, France, Norway

Therapeutic confirmatory (Phase III) EU CTIS Study details

A randomized crossover clinical trial regarding the blockage of the mineralocorticoid receptor using Eplerenone on the evolution of arterial stiffness in kidney patients one year after transplant: EVATRAN (The effect of Eplerenone on the evolution of Vasculopathy in renal transplant patients).

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Can Dapagliflozin Preserve Structure and Function in Transplanted Kidneys?

Norway

Therapeutic use (Phase IV) EU CTIS Study details

Kidney Transplantation trials by city

Kidney Transplantation in Toronto Kidney Transplantation in Vancouver Kidney Transplantation in Montreal Kidney Transplantation in Calgary Kidney Transplantation in Edmonton Kidney Transplantation in Ottawa Kidney Transplantation in Winnipeg Kidney Transplantation in Quebec City Kidney Transplantation in Hamilton Kidney Transplantation in Kitchener Kidney Transplantation in London Kidney Transplantation in Halifax Kidney Transplantation in New York Kidney Transplantation in Los Angeles Kidney Transplantation in Chicago Kidney Transplantation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease